Related Experiment Video
Updated: Sep 14, 2025

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
19.0K
Key Factors and Improving Paths of Promoting Long-Acting Injections in Communities in Beijing
Summary
Implementing long-acting injection policies faces barriers in evidence, adaptability, cost, and organizational factors. Addressing these requires coordinated policies, improved incentives, and enhanced education for successful promotion.
Area of Science:
- Health Policy
- Implementation Science
- Pharmaceutical Services
Background:
- Long-acting injections offer therapeutic advantages but face implementation challenges.
- Effective promotion policies are crucial for wider adoption and patient benefit.
Purpose of the Study:
- To identify key factors influencing the implementation of long-acting injection promotion policies.
- To propose actionable strategies for overcoming identified barriers.
Main Methods:
- Qualitative interviews with 46 stakeholders (health administrators, healthcare workers, patients) in Beijing.
- Utilized the Consolidated Framework for Implementation Research (CFIR).
- Proposed countermeasures based on expert recommendations.
Main Results:
- Identified barriers across evidence, adaptability, relative advantage, complexity, cost, patient needs, external collaboration, policies, organizational structure, and self-efficacy.
- Stakeholder perspectives revealed initial success but significant obstacles remain.
Conclusions:
- Policy coordination and adaptation are essential for effective long-acting injection promotion.
- Improving organizational incentives and strengthening individual advocacy and education are recommended.
- Addressing multifaceted barriers is key to successful implementation.
Related Concept Videos
Insulin Formulations: Types and Delivery
273
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
273
Insulin: Dosing Regimen and Adverse Effects
262
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
262
Drug Delivery: Miscellaneous Routes
468
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
468
Biopharmaceutics and Pharmacokinetics: Overview
2.5K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.5K
Drug Delivery: Parenteral Route
841
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
841
Community Based Intervention
95
Community-based interventions in mental health represent a paradigm shift from institution-centered care to treatments embedded within the fabric of local communities. By prioritizing inclusion and leveraging existing societal structures, this approach fosters a supportive environment conducive to addressing mental health challenges while promoting individual dignity and agency.
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
95

